Evidence map›Paper›PMID 37165900›Full record

Trial reportHypertension (Dallas, Tex. : 1979)2023

Evidence for Age Bias Contributing to Therapeutic Inertia in Blood Pressure Management: A Secondary Analysis of SPRINT.

Alexander R Zheutlin, Daniel K Addo, Joshua A Jacobs, Catherine G Derington, Jennifer S Herrick, Tom Greene, Eric L Stulberg, Dan R Berlowitz, Jeff D Williamson, Nicholas M Pajewski and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Hypertension (Dallas, Tex. : 1979), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Optimal Blood Pressure Targets with Age.Clinics in geriatric medicine · 2024
    Review
  6. Article
  7. Therapeutic inertia.Australian prescriber · 2024
    Review
4 · The record

Corrections and comments

  • Commented on by
    2023
5 · Who and what money

Authors and funding

12 authors.

Alexander R ZheutlinDepartment of Internal Medicine (A.R.Z.), Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.ORCID 0000-0002-5578-782X
Daniel K AddoIntermountain Healthcare Department of Population Health Sciences (D.K.A., J.A.J., C.G.D., J.S.H., T.G., A.P.B.), Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.ORCID 0000-0002-3450-6718
Joshua A JacobsIntermountain Healthcare Department of Population Health Sciences (D.K.A., J.A.J., C.G.D., J.S.H., T.G., A.P.B.), Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.ORCID 0000-0002-9621-9060
Catherine G DeringtonIntermountain Healthcare Department of Population Health Sciences (D.K.A., J.A.J., C.G.D., J.S.H., T.G., A.P.B.), Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.ORCID 0000-0001-7382-4607
Jennifer S HerrickIntermountain Healthcare Department of Population Health Sciences (D.K.A., J.A.J., C.G.D., J.S.H., T.G., A.P.B.), Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.ORCID 0000-0001-9257-8843
Tom GreeneIntermountain Healthcare Department of Population Health Sciences (D.K.A., J.A.J., C.G.D., J.S.H., T.G., A.P.B.), Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.
Eric L StulbergDepartment of Neurology (E.L.S.), Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.
Dan R BerlowitzDepartment of Public Health, University of Massachusetts-Lowell (D.R.B.).
Jeff D WilliamsonSection on Gerontology and Geriatric Medicine, Department of Internal Medicine (J.D.W.), Wake Forest University School of Medicine, Winston-Salem, NC.
Nicholas M PajewskiDepartment of Biostatistics and Data Science, Division of Public Health Sciences (N.M.P.), Wake Forest University School of Medicine, Winston-Salem, NC.ORCID 0000-0002-4447-6196
Mark A SupianoGeriatrics Division, Spencer Fox Eccles School of Medicine, University of Utah Center on Aging, Salt Lake City (M.A.S.).ORCID 0000-0002-5438-5087
Adam P BressIntermountain Healthcare Department of Population Health Sciences (D.K.A., J.A.J., C.G.D., J.S.H., T.G., A.P.B.), Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.ORCID 0000-0002-2259-5039

Funding

CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
The SPRINT Alzheimer's, Seniors and Kidney Study (SPRINT ASK)R01AG055606 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI REBOUSSIN, DAVID M, WILLIAMSON, JEFF DOUGLAS · 2017 to 2023
$9.9M
Patient Level Prediction of Clinical Outcomes and Cost-Effectiveness in SPRINT (Optimize-SPRINT)R01HL139837 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BRESS, ADAM P, MORAN, ANDREW EDWARD · 2018 to 2021
$3.2M
Guiding next steps for SPRINT-MIND implementation: Identifying high-benefit subgroups and comparative effects of ARB- vs. ACEI-based regimensR01AG065805 · NIA · UNIVERSITY OF UTAH · PI BRESS, ADAM P · 2020 to 2023
$2.7M
Utah Stimulating Access to Research in Residency Transition Scholar (StARRTS)R38HL143605 · NHLBI · UNIVERSITY OF UTAH · PI CONROY, MARGARET B, OKUYEMI, KOLAWOLE S · 2018 to 2021
$1.3M
Utah Stimulating Access to Research in ResidencyR38HL167282 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Margaret B Conroy, JOSEPH BARNEY STANFORD · 2023 to 2026
$924k
Using pharmacoepidemiology to optimize antihypertensive medication use to prevent aging-related multimorbidity: Midcareer investigator award in patient-oriented research and mentoring.K24AG080168 · NIA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Adam P Bress · 2023 to 2026
$793k
Genetic ancestry and antihypertensive medication responses in African AmericansK01HL133468 · NHLBI · UNIVERSITY OF UTAH · PI BRESS, ADAM P · 2016 to 2020
$787k
Understanding drivers of incident hypertension disparities among US Hispanics of diverse backgroundsK01MD014158 · NIMHD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ELFASSY, TALI · 2019 to 2022
$645k
NCATS NIH HHS UM1 TR004409NHLBI NIH HHS K01 HL133468NHLBI NIH HHS R01 HL139837NHLBI NIH HHS R38 HL143605NHLBI NIH HHS R38 HL167282NIA NIH HHS K24 AG080168NIA NIH HHS R01 AG055606NIA NIH HHS R01 AG065805NIMHD NIH HHS K01 MD014158
6 · The paper itself

Abstract

backgroundDespite evidence supporting the cardiovascular and cognitive benefits of intensive blood pressure management, older adults have the lowest rates of blood pressure control. We determined the association between age and therapeutic inertia (TI) in SPRINT (Systolic Blood Pressure Intervention Trial), and whether frailty, cognitive function, or gait speed moderate or mediate these associations.

methodsWe performed a secondary analysis of SPRINT of participant visits with blood pressure above randomized treatment goal. We categorized baseline age as <60, 60 to <70, 70 to <80, and ≥80 years and TI as no antihypertensive medication intensification per participant visit. Generalized estimating equations generated odds ratios for TI associated with age, stratified by treatment group based on nested models adjusted for baseline frailty index score (fit [frailty index, ≤0.10], less fit [0.10<frailty index≤0.21], and frail [0.21<frailty index]), cognitive function by Montreal cognitive assessment, and gait speed (participants ≥75 years of age), separately.

resultsParticipants 60 to <70, 70 to <80, and ≥80 years of age had a higher prevalence of TI in both treatment groups versus participants <60 years of age (standard: 59.7%, 60.5%, and 60.1% versus 56.0%; 29 527 participant visits; intensive: 55.1%, 57.2%, and 57.8% versus 53.8%; 47 129 participant visits). The adjusted odds ratios for TI comparing participants ≥80 versus <60 years of age were 1.32 (95% CI, 1.14-1.53) and 1.25 (95% CI, 1.11-1.41) in the standard and intensive treatment groups, respectively. Adjustment for frailty, cognitive function, or gait speed did not attenuate the association or demonstrate effect modification (all

conclusionsOlder age is associated with greater TI independent of physical or cognitive function, implying age bias in hypertension management.

Indexed as

FrailtyHypertensionAgedAged, 80 and overAntihypertensive AgentsBlood PressureHumansMiddle AgedRisk FactorsAntihypertensive Agentsfrailtyfunctional statusgoalshypertensionodds ratio

Identifiers

PMID37165900
PMCPMC10438422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.